Banking

Merck Earnings Meet Views, Sales Top With Stock In Buy Zone

Merck stock fell a fraction early Thursday after the pharmaceutical giant reported adjusted earnings of $1.31 per share on $11.4 billion in second-quarter sales.




X



On average, analysts polled by FactSet expected Merck (MRK) to earn $1.31 per share on $11.08 billion in sales.

In the year-earlier period, Merck reported earnings of $1.31 a share and $12.55 billion in sales.

For the year, the pharmaceutical giant guided to EPS of $5.47-$5.57 on sales of $46.4 billion to $4.74 billion. Merck stock analysts expected $5.52 earnings per share and $46.41 billion in sales.

In premarket trading on the stock market today, Merck stock dipped 0.3% to 78.09. Shares broke out of a saucer-with-handle base with a buy point at 77.85 on June 25 and has since bounded into and out of the 5% chase zone, according to MarketSmith.com.

However, the relative strength line for MRK stock has fallen sharply over the past year, and has declined over several years. That reflects the Dow Jones giant’s underperformance vs. the S&P 500 index.

More to follow.

Follow Allison Gatlin on Twitter at @IBD_AGatlin.

YOU MAY ALSO LIKE:

Pfizer Stock Lingers In Breakout Territory After Hiking Its Covid Vaccine Outlook

Bristol Myers Retakes Buy Point After ‘Solid’ Quarter, Though Generics Loom

IBD’s Leaderboard Is Turning 10! Help Us Celebrate

Learn How To Time The Market With IBD’s ETF Market Strategy

How To Research Growth Stocks: Why This IBD Tool Simplifies The Search For Top Stocks



Most Related Links :
reporterwings Governmental News Finance News

Source link

Back to top button